SWK Holdings to Participate in 2020 Colliers Institutional Investor Conference
SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will participate in the 2020 Colliers Institutional Investor Conference, taking place virtually on September 10, 2020 from 9 a.m.ET to 5 p.m. ET.
Mr. Black will host virtual one-on-one meetings with investors to discuss SWK Holdings’ business and investment strategy, and highlight recent corporate achievements, as well as anticipated milestones. Institutional investors are invited to request meeting times.
For questions and inquiries regarding the conference or to register for a one-on-one meeting, please contact your Colliers Securities sales representative.
About SWK Holdings:
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris Biopharma, whose core Peptelligence™ drug delivery technology creates oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its specialty finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company’s website at www.swkhold.com.
SOURCE SWK Holdings Corporation
Leave a Reply